Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015

Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015

Summary

GlobalData’s “Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global CRT devices market. The report identifies the key trends shaping and driving the dynamism in the global CRT devices market. The report also provides insights into the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global CRT devices sector.

Scope

- Annualized global CRT devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global CRT devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global CRT devices market in the long run.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global CRT devices market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global CRT devices market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Executive Summary 8
3 Global Cardiac Resynchronization Therapy Market : Market Characterization 9
3.1 Overview 9
3.2 Cardiac Resynchronization Therapy, Revenue ($ m), Historic, 2001 – 2008 9
3.3 Cardiac Resynchronization Therapy, Revenue ($ m), Forecast, 2008 – 2015 11
3.4 Cardiac Resynchronization Therapy: Market Dynamics 12
3.4.1 Market Drivers 12
3.4.1.1 Positive Clinical Trial Data to Bolster Growth 12
3.4.1.2 Increasing Prevalence of Congestive Heart Failure (CHF) to Drive the CRT Market 15
3.4.2 Market Restraints 15
3.4.2.1 High Device Cost a Growth Limiting Factor 15
3.4.2.2 Low Awareness and Slow Uptake of Technology in Developing Countries will hamper Growth 15
3.4.2.3 Availability of Alternative Pharmacological Therapies Resulting in Low Prescription Rates 15
3.4.2.4 Negative Market Impact Due to Device Recalls 15
3.5 Cardiac Resynchronization Therapy: Perception Analysis 16
3.6 Cardiac Resynchronization Therapy: Opportunities and Unmet Need 17
3.7 Key Takeaway 19
4 Global Cardiac Resynchronization Therapy Market : Competitive Assessment 20
4.1 Overview 20
4.2 Strategic Competitive Assessment 20
4.3 Cardiac Resynchronization Therapy Company Shares 2008 22
4.4 Product Profiles of the Major Marketed Products in the Cardiac Resynchronization Therapy Market 23
4.4.1 Concerto CRT-D 23
4.4.1.1 Overview 23
4.4.1.2 Efficacy 23
4.4.1.3 Safety Profile 23
4.4.1.4 Pricing 23
4.4.1.5 Clinical Study details 23
4.4.2 Promote Plus CRT-D 24
4.4.2.1 Overview 24
4.4.2.2 Efficacy 24
4.4.2.3 Safety 24
4.4.2.4 Pricing 24
4.4.3 Anthem CRT-P 25
4.4.3.1 Overview 25
4.4.3.2 Efficacy 25
4.4.3.3 Safety 25
4.4.3.4 Pricing 25
4.5 Key Takeaway 25
5 Global Cardiac Resynchronization Therapy Market: Pipeline Assessment 26
5.1 Overview 26
5.2 Strategic Pipeline Assessment 26
5.3 Cardiac Resynchronization Therapy – Pipeline by Clinical Phase of Development 29
5.4 Profiles of Promising Devices in Clinical Development 29
5.4.1 PARADYM sonR 29
5.4.1.1 Overview 29
5.4.1.2 Efficacy 29
5.4.1.3 Safety 30
5.4.1.4 Clinical Study Details 30
5.4.2 Paradym CRT PhD 30
5.4.2.1 Overview 30
5.4.2.2 Efficacy 30
5.4.2.3 Safety 30
5.4.2.4 Clinical Study Details 30
5.4.3 Promote Quadra CRT-D 31
5.4.3.1 Overview 31
5.4.3.2 Efficacy 31
5.4.3.3 Safety 31
5.4.3.4 Clinical Study Details 31
5.5 Cardiac Resynchronization Therapy Market: List of Pipeline Products 33
5.6 Key Takeaway 33
6 Global Cardiac Resynchronization Therapy Market : Implications for Future Market Competition 34
6.1 Strategic Competitor Assessment 35
7 Global Cardiac Resynchronization Therapy Market: Emerging Companies 36
7.1 Introduction 36
7.2 Boston Scientific 36
7.2.1 Overview 36
7.2.2 Boston Scientific Cardiac Resynchronization Therapy Portfolio 36
7.2.2.1 Marketed Products 36
7.2.2.2 Pipeline Products 37
7.3 St. Jude Medical 37
7.3.1 Overview 37
7.3.2 St. Jude Medical Cardiac Resynchronization Therapy Portfolio 37
7.3.2.1 Marketed Products 37
7.3.2.2 Pipeline Products 38
7.4 Sorin Group 38
7.4.1 Overview 38
7.4.2 Sorin Cardiac Resynchronization Therapy Portfolio 38
7.4.2.1 Marketed Products 38
7.4.2.2 Pipeline Products 39
7.5 Odem Medical 39
7.5.1 Overview 39
7.5.2 Odem Medical Cardiac Resynchronization Therapy Portfolio 39
7.5.2.1 Marketed Products 39
7.5.2.2 Pipeline Products 39
8 Appendix 40
8.1 Definitions 40
8.1.1 Cardiac Resynchronisation Therapy 40
8.1.1.1 Cardiac Resynchronisation Therapy – Defibrillator 40
8.1.1.2 Cardiac Resynchronisation Therapy – Pacemaker 40
8.2 Research Methodology 41
8.3 Secondary Research 41
8.4 Primary Research 42
8.5 Models 42
8.6 Forecasts 43
8.7 Expert Panels 43
8.8 GlobalData Consulting 43
8.9 Contact Us 44
8.10 Disclaimer 44